- ·The complete investor list: 17 names
- ·Watch Biomemory: the Monday email on marks, rounds and moves
Biomemory funding history
No funding rounds for Biomemory are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Biomemory valuation
Biomemory's last known valuation is $38.5 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How Biomemory's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Biomemory, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Biomemory
- What is Biomemory worth?
- Biomemory's last known valuation is $38.5M.
- How much has Biomemory raised?
- Biomemory has raised $23.4M in total funding across its recorded rounds.